Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹1,031 Cr₹915 Cr₹997 Cr₹364 Cr₹791 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹1,031 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹1,031 Cr
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹1,031 Cr
12.75
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹54,302.3 Cr -1.3% 12.5% 76.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.3%

12.5%

76.4%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses